ORIC PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
ORIC PHARMACEUTICALS, INC. (ORIC) had Shares Outstanding (Cover Page) of 103.65 million shares as of 2026-07-27, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-27: Entity Common Stock, Shares Outstanding 103.65M shares.
- 2026-04-27: Entity Common Stock, Shares Outstanding 103.52M shares.
- 2026-02-12: Entity Common Stock, Shares Outstanding 100.36M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 97.39M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-27 | 103.65M shares 10-Q · filed 2026-08-03 |
| 2026-04-27 | 103.52M shares 10-Q · filed 2026-05-04 |
| 2026-02-12 | 100.36M shares 10-K · filed 2026-02-23 |
| 2025-11-05 | 97.39M shares 10-Q · filed 2025-11-13 |
| 2025-08-05 | 97.12M shares 10-Q · filed 2025-08-12 |
| 2025-04-28 | 71.09M shares 10-Q · filed 2025-05-05 |
| 2025-02-04 | 71.03M shares 10-K · filed 2025-02-18 |
| 2024-10-31 | 70.57M shares 10-Q · filed 2024-11-12 |
| 2024-07-31 | 70.54M shares 10-Q · filed 2024-08-12 |
| 2024-04-26 | 67.42M shares 10-Q · filed 2024-05-06 |
| 2024-03-04 | 67.38M shares 10-K · filed 2024-03-11 |
| 2023-10-31 | 54.55M shares 10-Q · filed 2023-11-06 |
| 2023-08-03 | 54.53M shares 10-Q · filed 2023-08-10 |
| 2023-05-02 | 45.09M shares 10-Q · filed 2023-05-08 |
| 2023-03-07 | 45.09M shares 10-K · filed 2023-03-16 |
| 2022-11-01 | 39.58M shares 10-Q · filed 2022-11-07 |
| 2022-08-03 | 39.58M shares 10-Q · filed 2022-08-11 |
| 2022-05-04 | 39.48M shares 10-Q · filed 2022-05-09 |
| 2022-03-16 | 39.43M shares 10-K · filed 2022-03-21 |
| 2021-11-03 | 39.38M shares 10-Q · filed 2021-11-08 |
| 2021-08-05 | 39.32M shares 10-Q · filed 2021-08-10 |
| 2021-04-30 | 36.70M shares 10-Q · filed 2021-05-06 |
| 2021-02-28 | 36.70M shares 10-K · filed 2021-03-23 |
| 2020-10-30 | 30.84M shares 10-Q · filed 2020-11-05 |
| 2020-07-31 | 29.96M shares 10-Q · filed 2020-08-05 |
| 2020-05-01 | 29.90M shares 10-Q · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |